Regeneron (REGN) Tops Q1 EPS by 53c
Tweet
Share
E-mail
Get Alerts REGN Hot Sheet
Price: $664.52 -0.51%
Revenue Growth %: +3.3%
Financial Fact:
Research and development: 543.05M
Today's EPS Names:
CCEL, FEIM, PLG, More
Revenue Growth %: +3.3%
Financial Fact:
Research and development: 543.05M
Today's EPS Names:
CCEL, FEIM, PLG, More
Join SI Premium – FREE
Regeneron (NASDAQ: REGN) reported Q1 EPS of $10.09, $0.53 better than the analyst estimate of $9.56. Revenue for the quarter came in at $3.16 billion versus the consensus estimate of $3 billion.
For earnings history and earnings-related data on Regeneron (REGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
- Regeneron Pharma (REGN) PT Lowered to $769 at Truist Securities
- Regeneron Pharma (REGN) PT Lowered to $730 at Morgan Stanley
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
